Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea · Delayed Price · Currency is KRW 1,868.00
+141.00 (8.16%)
At close: Jun 29, 2026
Green Lifescience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 51,017 | 40,340 | 24,861 | 22,369 | 36,505 | 25,338 |
Other Revenue | -0 | -0 | - | 0 | 0 | 0 |
| 51,017 | 40,340 | 24,861 | 22,369 | 36,505 | 25,338 | |
Revenue Growth (YoY) | 119.98% | 62.26% | 11.14% | -38.72% | 44.07% | 3.16% |
Cost of Revenue | 46,871 | 37,872 | 21,881 | 24,683 | 37,861 | 27,608 |
Gross Profit | 4,146 | 2,467 | 2,980 | -2,313 | -1,356 | -2,270 |
Selling, General & Admin | 1,943 | 1,909 | 1,685 | 1,996 | 2,027 | 2,085 |
Research & Development | 216.89 | 292.17 | 734.99 | 112.11 | 425.82 | 109.59 |
Other Operating Expenses | 1.54 | 1.54 | 11.75 | 3.08 | 7.57 | 0.53 |
Operating Expenses | 2,222 | 2,263 | 2,603 | 2,330 | 2,602 | 2,378 |
Operating Income | 1,924 | 204.29 | 376.91 | -4,643 | -3,958 | -4,648 |
Interest Expense | -229.17 | -242.17 | -238.06 | -240.43 | -113.34 | -22.2 |
Interest & Investment Income | 399.33 | 390.02 | 453.73 | 697.58 | 626.6 | 674.92 |
Currency Exchange Gain (Loss) | 658.18 | 11.24 | 988.53 | -55.15 | -5.29 | -18.17 |
Other Non Operating Income (Expenses) | -81.53 | -44.58 | 125.65 | -65.72 | -106.51 | 181.34 |
EBT Excluding Unusual Items | 2,671 | 318.81 | 1,707 | -4,307 | -3,557 | -3,832 |
Gain (Loss) on Sale of Investments | 1,696 | 1,148 | -144.81 | 43.71 | 694.8 | 416.74 |
Gain (Loss) on Sale of Assets | -0 | -0 | - | - | 1.39 | -2.24 |
Asset Writedown | -1,357 | -1,357 | - | -12,095 | - | - |
Pretax Income | 3,011 | 110.13 | 1,562 | -16,358 | -2,860 | -3,418 |
Income Tax Expense | - | - | - | - | 665.17 | -282.01 |
Net Income | 3,011 | 110.13 | 1,562 | -16,358 | -3,526 | -3,136 |
Net Income to Common | 3,011 | 110.13 | 1,562 | -16,358 | -3,526 | -3,136 |
Net Income Growth | - | -92.95% | - | - | - | - |
Shares Outstanding (Basic) | 19 | 19 | 19 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 20 | 20 | 20 |
Shares Change (YoY) | 1.46% | -0.24% | -3.61% | -0.19% | - | - |
EPS (Basic) | 155.32 | 5.74 | 81.18 | -819.47 | -176.28 | -156.79 |
EPS (Diluted) | 155.32 | 5.74 | 81.18 | -819.47 | -176.28 | -156.79 |
EPS Growth | - | -92.93% | - | - | - | - |
Free Cash Flow | -2,833 | -495.66 | -255.13 | -125.67 | -6,030 | -2,832 |
Free Cash Flow Per Share | -146.14 | -25.82 | -13.26 | -6.30 | -301.49 | -141.61 |
Gross Margin | 8.13% | 6.12% | 11.98% | -10.34% | -3.72% | -8.96% |
Operating Margin | 3.77% | 0.51% | 1.52% | -20.76% | -10.84% | -18.34% |
Profit Margin | 5.90% | 0.27% | 6.28% | -73.13% | -9.66% | -12.38% |
Free Cash Flow Margin | -5.55% | -1.23% | -1.03% | -0.56% | -16.52% | -11.18% |
EBITDA | 2,698 | 994.17 | 1,145 | -2,167 | -1,189 | -2,083 |
EBITDA Margin | 5.29% | 2.46% | 4.61% | -9.69% | -3.26% | -8.22% |
D&A For EBITDA | 773.4 | 789.88 | 768.54 | 2,476 | 2,769 | 2,565 |
EBIT | 1,924 | 204.29 | 376.91 | -4,643 | -3,958 | -4,648 |
EBIT Margin | 3.77% | 0.51% | 1.52% | -20.76% | -10.84% | -18.34% |
Advertising Expenses | - | - | - | 2 | - | - |